Detalhe da pesquisa
1.
Gene expression profiling of plasma cells at myeloma relapse from tandem transplantation trial Total Therapy 2 predicts subsequent survival.
Blood
; 113(26): 6572-5, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389881
2.
Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols.
Blood
; 114(7): 1299-305, 2009 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19515721
3.
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.
Blood
; 112(8): 3115-21, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18492953
4.
Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease.
Blood
; 112(8): 3122-5, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18669874
5.
Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
N Engl J Med
; 354(10): 1021-30, 2006 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-16525139
6.
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
Clin Cancer Res
; 13(23): 7073-9, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056185
7.
Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.
Clin Lymphoma Myeloma
; 6(6): 469-74, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16796777
8.
Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma.
Cancer
; 113(2): 355-9, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18470907
9.
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
Blood
; 111(1): 94-100, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17895401
10.
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
Blood
; 109(4): 1692-700, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17023574
11.
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
Br J Haematol
; 136(3): 393-9, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17156398
12.
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
Blood
; 110(3): 827-32, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17416735
13.
Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics.
Br J Haematol
; 137(6): 530-6, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17489983
14.
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
Br J Haematol
; 138(2): 176-85, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17593024
15.
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.
J Clin Oncol
; 25(9): 1121-8, 2007 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17296972
16.
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
Blood
; 109(6): 2276-84, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17105813
17.
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies.
Blood
; 107(7): 2633-8, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322468
18.
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.
Blood
; 108(5): 1724-32, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16705089
19.
The molecular classification of multiple myeloma.
Blood
; 108(6): 2020-8, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16728703
20.
Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12.
Cancer Immunol Immunother
; 50(11): 625-37, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11807626